---
figid: PMC9227908__pharmaceutics-14-01303-g001
figtitle: 'Metabolic Reprogramming in Cancer Cells: Emerging Molecular Mechanisms
  and Novel Therapeutic Approaches'
organisms:
- Candida dubliniensis
- Panax ginseng
- Homo sapiens
- Mus musculus
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC9227908
filename: pharmaceutics-14-01303-g001.jpg
figlink: /pmc/articles/PMC9227908/figure/pharmaceutics-14-01303-f001/
number: F1
caption: Carbohydrate metabolism and mediators of metabolic reprogramming. Cancer
  cells must acquire a greater amount of nutrients, especially glucose. One of the
  mediators is HIF-1, which increases glucose uptake through the induction of GLUT-1,
  GLUT-4 and GLUT-1; simultaneosly, it can also be stimulated by TGF-β through the
  PI3K/AKT/mTOR pathway. Other important mediators are p53 that plays a protective
  role against ROS. GLUT, glucose transporters; Glu-6-P, glucose 6-phosphate; Fru-6-P,
  fructose 6-bisphosphate; Fru-1,6-P, fructose 1,6-bisphosphate; Fru-2,6-P, fructose
  2,6-bisphosphate; GA-3-P, glyceraldehyde 3-phosphate; PEP, phosphoenolpyruvate;
  HK, hexokinase; TGFB, transforming growth factor beta; PFK1, phosphofructokinase
  1; PKM2, pyruvate kinase M2; LDHA, lactate dehydrogenase A; G6PD, glucose-6-phosphate
  dehydrogenase; 6-PGL, 6-phosphogluconolactonase; NADP+, nicotinamide adenine dinucleotide
  phosphate; NADPH, reduced form of NADP; GSSG, glutathione disulfide; GSH, glutathione;
  H2O2, hydrogen peroxide; TIGAR, Tp53-induced glycolysis and apoptosis regulator;
  FGF, fibroblast growth factor; HIF-1, hypoxia-inducible factor 1; PPP, pentose phosphate
  pathway; KRAS, Kirsten-ras; RPIA, ribose-5 phosphate isomerase; MYC, proto-oncogene;
  Ribulose-5-P, ribulose 5-phosphate; Ribose-5-P, ribose 5-phosphate; SGLT1/2, sodium-glucose
  cotransporter-1/2.
papertitle: 'Metabolic Reprogramming in Cancer Cells: Emerging Molecular Mechanisms
  and Novel Therapeutic Approaches.'
reftext: Carla Navarro, et al. Pharmaceutics. 2022 Jun;14(6):1303.
year: '2022'
doi: 10.3390/pharmaceutics14061303
journal_title: Pharmaceutics
journal_nlm_ta: Pharmaceutics
publisher_name: MDPI
keywords: metabolic reprogramming | tumor microenvironment | energy metabolism | neoplasms
  | carbohydrates | inflammation | immunotherapy
automl_pathway: 0.9266949
figid_alias: PMC9227908__F1
figtype: Figure
redirect_from: /figures/PMC9227908__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9227908__pharmaceutics-14-01303-g001.html
  '@type': Dataset
  description: Carbohydrate metabolism and mediators of metabolic reprogramming. Cancer
    cells must acquire a greater amount of nutrients, especially glucose. One of the
    mediators is HIF-1, which increases glucose uptake through the induction of GLUT-1,
    GLUT-4 and GLUT-1; simultaneosly, it can also be stimulated by TGF-β through the
    PI3K/AKT/mTOR pathway. Other important mediators are p53 that plays a protective
    role against ROS. GLUT, glucose transporters; Glu-6-P, glucose 6-phosphate; Fru-6-P,
    fructose 6-bisphosphate; Fru-1,6-P, fructose 1,6-bisphosphate; Fru-2,6-P, fructose
    2,6-bisphosphate; GA-3-P, glyceraldehyde 3-phosphate; PEP, phosphoenolpyruvate;
    HK, hexokinase; TGFB, transforming growth factor beta; PFK1, phosphofructokinase
    1; PKM2, pyruvate kinase M2; LDHA, lactate dehydrogenase A; G6PD, glucose-6-phosphate
    dehydrogenase; 6-PGL, 6-phosphogluconolactonase; NADP+, nicotinamide adenine dinucleotide
    phosphate; NADPH, reduced form of NADP; GSSG, glutathione disulfide; GSH, glutathione;
    H2O2, hydrogen peroxide; TIGAR, Tp53-induced glycolysis and apoptosis regulator;
    FGF, fibroblast growth factor; HIF-1, hypoxia-inducible factor 1; PPP, pentose
    phosphate pathway; KRAS, Kirsten-ras; RPIA, ribose-5 phosphate isomerase; MYC,
    proto-oncogene; Ribulose-5-P, ribulose 5-phosphate; Ribose-5-P, ribose 5-phosphate;
    SGLT1/2, sodium-glucose cotransporter-1/2.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Trp53
  - Ldha
  - Tgfb1
  - Ltbp1
  - Myc
  - Nol3
  - Tigar
  - Pkm
  - Prep
  - Ptpn22
  - Fndc5
  - Hk
  - Decr1
  - G6pdx
  - H20
  - Slc5a2
  - Slc5a1
  - Kras
  - Rpia
  - TP53
  - TP63
  - TP73
  - LDHA
  - TGFB1
  - TGFB2
  - TGFB3
  - MYC
  - TIGAR
  - PKM
  - PKLR
  - FGF1
  - FGF2
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FGF10
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - PAEP
  - PREP
  - PTPN22
  - PFKM
  - DECR1
  - G6PD
  - UBL4A
  - SLC5A2
  - SLC5A1
  - PGLS
  - PGD
  - KRAS
  - NRAS
  - RPIA
  - p53
  - betaTub60D
  - hth
  - dpp
  - gbb
  - put
  - mav
  - bnl
  - Pep
  - bgcn
  - Pfk
  - Zw
  - Pgls
  - na
  - pg
  - Pgd
---
